President-elect Donald Trump's transition team reportedly tapped a former senior health official from the president-elect's ...
The Department of Health and Human Services Jan. 17 announced 15 Medicare Part D drugs selected for the latest round of price ...
The harmful effects of private equity in the healthcare delivery system "deserves ongoing scrutiny and greater research," HHS said in a Jan. 15 report .
Secretary Xavier Becerra spoke to The Washington Post about falling trust in his department since the coronavirus pandemic.
The US Department of Health and Human Services (HHS) on January 6, 2025 issued a notice of proposed rulemaking (NPRM) seeking feedback on ...
Pharmaceutical company Novartis has filed a lawsuit against the HHS over the way drugs are priced under the 340B program.
Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...
Last June, the Supreme Court issued its decision in Securities and Exchange Commission v. Jarkesy, which holds that the ...
AI is safe and trustworthy when deployed in healthcare. The plan emphasizes technical assistance for under-resourced ...
A new Health and Human Services report is calling for greater transparency in long-term care ownership, calling out private ...
President-elect Trump’s nominee for Health and Human Services Secretary – Robert F. Kennedy, Jr. – is an interesting fellow ...